SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The filing discloses the equity securities held by Lloyds Banking Group Plc as of the reporting period ending September 30, 2017. The document serves as a regulatory disclosure of investment holdings rather than a financial performance report of Lloyds Banking Group itself.
Key Financial Metrics and Holdings
The filing details a portfolio of U.S. equity securities. Key metrics derived from the table include:
- Total Portfolio Value: The filing lists individual position values in thousands of dollars (Column 4). The aggregate value is not explicitly summed in the text, but the largest single position is JPMorgan Chase & Co. with a value of $2,693,000.
- Number of Positions: The table lists approximately 60 distinct equity positions, including common stocks and exchange-traded funds (ETFs).
- Voting Authority: For all listed positions, Lloyds Banking Group Plc reports Sole voting authority (Column 7), with no shared or none authority reported.
- Derivatives: No put or call options are reported in the "PRN AMT" (Principal Amount) columns for these positions.
Material Changes and Portfolio Composition
As this is a snapshot of holdings at a specific date, the filing does not provide comparative data against a prior period to determine material changes in position size or total portfolio value. However, the composition reveals a diversified exposure to U.S. sectors:
- Financials: Significant holdings in JPMorgan Chase & Co. (28,209 shares), Regions Financial Corp (7,237 shares), and M&T Bank Corp (1,181 shares).
- Technology: Positions in Oracle Corp (4,954 shares), Cognizant Technology Solutions (2,940 shares), and Apple Inc. (182 shares).
- Healthcare: Holdings in American International Group Inc (2,421 shares), Pfizer Inc (444 shares), and Gilead Sciences Inc (1,805 shares).
- Consumer Staples & Discretionary: Investments in PepsiCo Inc, TJX Cos Inc, and Estee Lauder Cos Inc.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, or specific risk factors related to Lloyds Banking Group's operations. The document includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. There are no unusual items or contingencies disclosed within the scope of this specific information table.
Investor Verification Checklist
- Verify the total aggregate value of the portfolio by summing the "VALUE" column, as the total is not explicitly stated in the text.
- Confirm the identity of the reporting manager; while the metadata indicates Lloyds Banking Group Plc, the table lists "DFND" in the investment discretion column, which may require cross-referencing with the full Form 13F cover page.
- Check subsequent filings (e.g., Q4 2017) to analyze turnover and changes in the largest positions, specifically JPMorgan Chase & Co. and Oracle Corp.
- Review the CUSIP numbers to ensure the specific share classes (e.g., Class A vs. Class B) match the investor's expectations for the listed issuers.